Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - June 2009

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for June 2009 (PDF).

This issue contains stop press information about a potential interaction between clopidogrel and proton pump inhibitors, counterfeit NovoFine® needles and hepatitis risk from incorrect use of lancet devices. Drug safety advice covers the following areas:

  • Antipsychotics: risk of venous thromboembolic events
  • Chloral hydrate and Triclofos: not first-line options for insomnia
  • Oral salicylate gels: not for use in those younger than age 16 years
  • Topical ketoprofen: reminder on risk of photosensitivity reactions

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - June 2009' on Email Share 'Drug Safety Update - June 2009' on Delicious Share 'Drug Safety Update - June 2009' on Digg Share 'Drug Safety Update - June 2009' on Facebook Share 'Drug Safety Update - June 2009' on Google+ Share 'Drug Safety Update - June 2009' on reddit Share 'Drug Safety Update - June 2009' on StumbleUpon Share 'Drug Safety Update - June 2009' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - June 2009”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer